Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rainbow Childrens MedicareBOM:543524 -1.16%90 Return-on-Tangible-Equity is 16.71% as of Jun. 2026, which is 9% below its 10-year median of 18.42. GuruFocus rates BOM:543524 with a GF Score™ of 90/100 and a GF Value™ of ₹1,703.50 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 577 Healthcare Providers & Services companies, Rainbow Childrens Medicare ranks better than 67.24% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Rainbow Childrens Medicare's annualized net income for the quarter that ended in Jun. 2026 was ₹2,423 Mil. Rainbow Childrens Medicare's average shareholder tangible equity for the quarter that ended in Jun. 2026 was ₹14,503 Mil. Therefore, Rainbow Childrens Medicare's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 16.71%.
The historical rank and industry rank for Rainbow Childrens Medicare's Return-on-Tangible-Equity or its related term are showing as below:
BOM:543524'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.51 Med: 18.42 Max: 26.61
Current: 20.26
During the past 8 years, Rainbow Childrens Medicare's highest Return-on-Tangible-Equity was 26.61%. The lowest was 9.51%. And the median was 18.42%.
BOM:543524's Return-on-Tangible-Equity is ranked better than 67.24% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs BOM:543524: 20.26
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Rainbow Childrens Medicare Return-on-Tangible-Equity Related Terms
Rainbow Childrens Medicare Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543524 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Rainbow Childrens Medicare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rainbow Childrens Medicare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rainbow Childrens Medicare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Rainbow Childrens Medicare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 16.71% mean?
Rainbow Childrens Medicare (BOM:543524) has a Return-on-Tangible-Equity of 16.71% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rainbow Childrens Medicare and its competitors. This is near median its historical median of 18.42. Over the past decade, Rainbow Childrens Medicare's Return-on-Tangible-Equity has ranged from 9.51 to 26.61. According to the industry distribution chart, Rainbow Childrens Medicare ranks #189 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 32.8%.
Is Rainbow Childrens Medicare's Return-on-Tangible-Equity too high?
Rainbow Childrens Medicare's current Return-on-Tangible-Equity of 16.71% is near median its 10-year median of 18.42. Over the past 10 years, this metric has ranged from a low of 9.51 to a high of 26.61. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.62. Rainbow Childrens Medicare's value of 16.71% is 57.3% above this industry median. Based on the distribution chart, Rainbow Childrens Medicare ranks #189 out of 577 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Rainbow Childrens Medicare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rainbow Childrens Medicare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rainbow Childrens Medicare ranks #189 out of 577 companies for Return-on-Tangible-Equity. This puts Rainbow Childrens Medicare in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.62. Rainbow Childrens Medicare's value of 16.71% is 57.3% above this benchmark. Historically, Rainbow Childrens Medicare's own Return-on-Tangible-Equity has ranged from 9.51 to 26.61 over the past decade. While the company's 10-year median is 18.42 vs. the industry median of 10.62, Rainbow Childrens Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.62, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rainbow Childrens Medicare's current Return-on-Tangible-Equity of 16.71% is 57.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rainbow Childrens Medicare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rainbow Childrens Medicare's current Return-on-Tangible-Equity is 16.71%, which is near median its own 10-year median of 18.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rainbow Childrens Medicare stock overvalued right now?
Based on GuruFocus' analysis, Rainbow Childrens Medicare (BOM:543524) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,703.50, compared to a current price of ₹1,537.60 — trading 9.7% below its estimated fair value. The current Return-on-Tangible-Equity is 16.71%, which is near median its 10-year median of 18.42 and 57.3% above the Healthcare Providers & Services industry median of 10.62. Rainbow Childrens Medicare's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Rainbow Childrens Medicare (BOM:543524), the current Return-on-Tangible-Equity is 16.71% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rainbow Childrens Medicare (BOM:543524) Overvalued in 2026?
Based on GuruFocus' analysis, Rainbow Childrens Medicare stock appears to be undervalued.
The current stock price of ₹1,537.60 is trading 9.7% below its estimated GF Value™ of ₹1,703.50.
GuruFocus considers Rainbow Childrens Medicare to be Modestly Undervalued.
Key valuation signals for BOM:543524:
Return-on-Tangible-Equity: 16.71% (near median its 10-year median of 18.42)
GF Value™: ₹1,703.50 vs. price of ₹1,537.60 (9.7% below fair value)
Industry Position: 57.3% above the Healthcare Providers & Services median (#189 of 577)
No single metric tells the full story. See the BOM:543524 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rainbow Childrens Medicare Ltd operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology, which includes normal and complex obstetric care, and multidisciplinary fetal care, perinatal genetic and fertility care. Medical and Healthcare services have been considered the only reportable segment.
90GF Score
Get the complete analysis for BOM:543524
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543524 has been successfully added to your 
